U.S. Consumer Services Stock News

If you have been wondering whether Chart Industries at around $205 a share is still a smart buy or already priced for perfection, you are in the right place. The stock has crept up modestly in the short term, with returns of 0.3% over the last week, 1.1% over the last month, and 8.4% year to date, building on a much bigger 76.5% gain over three years and 83.8% over five. Recent headlines have focused on Chart Industries as a key player in cryogenic equipment and clean energy infrastructure...

Wondering if TE Connectivity is still worth buying after its big run up, or if you are turning up late to the party? This piece will walk through what the current price is really baking in. Even after a small pullback of around -1.8% over the last week and -3.0% over the past month, the stock is still up an impressive 63.7% year to date and 55.7% over the last year, more than doubling over three years and five years. Recent market interest has been shaped by TE Connectivity's positioning in...

MannKind Corporation recently reported that the FDA accepted its supplemental New Drug Application for the FUROSCIX ReadyFlow Autoinjector, a rapid subcutaneous furosemide delivery device for adults with chronic heart failure or chronic kidney disease, with a PDUFA target action date of July 26, 2026. If approved, ReadyFlow could meaningfully change at-home management of fluid buildup by cutting administration time from five hours to under 10 seconds while showing bioavailability comparable...

If you are wondering whether Jackson Financial at around $105 is still good value after its huge run, or if the easier gains have already been made, this breakdown will help you size up the opportunity with a cool head. The stock has climbed 7.7% over the last week, 12.0% in the past month, and is now up 20.6% year to date and 258.8% over three years. This naturally raises questions about how much upside is left versus the risk of a pullback. Recently, investors have been paying closer...

West Pharmaceutical Services (WST) has been drifting lower this year, and with the stock down about 19% year to date, investors are starting to revisit the story with a fresh valuation lens. See our latest analysis for West Pharmaceutical Services. The recent pullback has come despite steady underlying growth, with the 90 day share price return of 3.89% only partially offsetting the 18.52% year to date share price decline and softer 1 year total shareholder return of 18.67%. This suggests...

Group 1 Automotive (GPI) has quietly delivered strong multi year returns, even as the stock has slipped about 3% over the past day and 11% over the past 3 months. That disconnect has value investors taking a closer look. See our latest analysis for Group 1 Automotive. At around $413.74, the recent pullback in Group 1 Automotive’s share price contrasts with its substantial three and five year total shareholder returns. This suggests that momentum has cooled a little, even as the longer term...

S&P Global (SPGI) is leaning hard into enterprise AI, pairing a new multi year partnership with Google Cloud and fresh AWS integrations to push its data deeper into customers everyday workflows. See our latest analysis for S&P Global. The steady drumbeat of AI partnerships and fresh debt issuance has not yet translated into a breakout move, with the share price at $501.03 and a roughly flat 1 year total shareholder return. However, a strong 3 year total shareholder return suggests the long...

Jabil (JBL) just got caught in the latest market rotation, sliding after investors stepped back from AI exposed manufacturers. But that pullback is colliding with a busy stretch of operational and governance developments. See our latest analysis for Jabil. Despite the latest 5.1% one day share price drop to about $222, Jabil still shows strong momentum, with a roughly mid 50s year to date share price return and a powerful multi year total shareholder return above 400%. This suggests investors...

In early December 2025, Huntington Bancshares reduced its prime rate from 7% to 6.75%, following an earlier cut in October, and its board has declared a US$356.25 per-share quarterly dividend on its 5.70% Series I Non-Cumulative Perpetual Preferred Stock, payable in March 2026. This prime rate cut directly lowers borrowing costs for customers on variable-rate products and offers fresh insight into how Huntington is positioning its balance sheet and loan growth priorities amid changing...

Investors may be wondering if Parsons at around $63 is starting to look like value after its run up over the last few years, or if it is still pricing in too much optimism. The stock has pulled back sharply, down about 5% over the last week, 26.7% over the past month, and 30% year to date, even though it is still up roughly 80.3% over five years. That reversal comes as investors respond to shifting sentiment around government and critical infrastructure spending, along with a broader...

Wondering if Yext is actually a bargain or just another volatile tech name? You are not alone, and that is exactly what we are going to unpack here. The stock is up a solid 27.8% over the last year despite a -6.3% slip in the past week and a -4.3% dip over the last month, which hints that sentiment is still cautiously optimistic after a tough 5 year stretch of -47.8%. Recently, Yext has stayed in the conversation as investors reassess digital search and AI driven marketing tools, especially...

Barclays just kicked off coverage on IDEXX Laboratories (IDXX) with a favorable view, adding to a run of upbeat analyst calls as the company leans into global expansion and rising demand for its diagnostics platform. See our latest analysis for IDEXX Laboratories. That upbeat backdrop comes after a sharp re-rating, with the share price now at $704.2. Despite a slightly negative 30 day share price return, a strong year to date share price gain and robust multi year total shareholder returns...

In recent months, Markel Group Inc., led by CEO Tom Gayner, has sharpened its insurance focus by exiting loss-making reinsurance, tightening underwriting standards, and prioritizing higher-margin specialty lines while expanding internationally, where operations now generate about a quarter of gross written premiums. An important angle for long-term investors is the combination of this refocus with meaningful insider stock ownership, which signals strong management alignment as Markel leans...

NCR Atleos (NATL) is in focus after expanding its Allpoint Network, enabling Knoxville TVA Employees Credit Union members to make cash deposits at 3,500 branded ATMs nationwide, including new deposit locations across Tennessee. See our latest analysis for NCR Atleos. NCR Atleos shares now trade at $38.71, and that Knoxville TVA deal helps explain why the year to date share price return of 13.62 percent and 1 year total shareholder return of 16.46 percent point to gradually improving momentum...

On December 3, 2025, Stifel reiterated its Buy rating on Hillman Solutions, describing the company as a leading hardware-products distributor with strong gross profit margins and resilience in a flat home improvement market. Analysts also emphasized Hillman’s discounted valuation relative to peers, arguing this gap, combined with its position to benefit from a future home improvement recovery, underpins a more constructive long-term view. We’ll now examine how renewed analyst confidence in...

Coty’s controlling shareholder JAB Holdings has moved to overhaul the beauty group’s leadership, prompting chair Peter Harf to step down and signaling the expected departure of CEO Sue Nabi after a period of weak performance. This reshuffle raises fresh questions about how quickly new leadership can clarify Coty’s long-term direction, particularly around its ongoing strategic review and category growth priorities. Next, we’ll examine how this leadership shake-up might influence Coty’s...

Wondering if T-Mobile US at around $195 a share is starting to look like a deal, or if the market still has it about right? You are not alone, as plenty of investors are asking the same thing. The stock has slid recently, with returns of around -6.9% over the last week, -8.2% over the last month, and -11.1% year to date. However, the 3-year and 5-year returns of 41.9% and 53.1% still point to a longer-term success story. Part of that pullback reflects shifting sentiment across telecoms as...

If you are wondering whether Innodata is still a smart buy after its huge run, or if most of the upside is already priced in, you are not alone in trying to figure out what this stock is really worth. Despite pulling back around 9.3% over the last week and 15.4% over the past month, Innodata is still up an eye catching 32.7% year to date, 51.9% over the last year, and 1706.9% over three years and 927.5% over five years. That kind of performance has coincided with growing enthusiasm around AI...

Sabine Royalty Trust (SBR) just paired fresh December production figures with a new cash distribution, giving income-focused investors a clear snapshot of both current output and near term payout momentum. See our latest analysis for Sabine Royalty Trust. Despite the latest update, Sabine Royalty Trust’s unit price has eased back to $69.03, with softer recent share price returns but a still solid one year total shareholder return suggesting momentum is cooling rather than collapsing. If...

DuPont de Nemours has completed the separation of its electronics division into Qnity Electronics, Inc., reported strong third-quarter results driven by higher volumes, and launched a US$2.00 billion share repurchase program amid ongoing operational improvements. This combination of portfolio reshaping, volume-led earnings strength, and capital returns signals a clearer focus on healthcare and water businesses as future growth engines. We’ll now examine how the Qnity spin-off and new US$2.00...

Essex Property Trust (ESS) just tapped the bond market, issuing 350 million dollars of 4.875% senior notes due 2036. The company aims to tidy up near term debt and keep some dry powder for future deals. See our latest analysis for Essex Property Trust. That backdrop helps explain why, despite a 1 month share price return of just over 1% and a recent dividend affirmation, Essex’s 1 year total shareholder return is still negative, even though its 3 year total shareholder return remains firmly...

Earlier this week, Truist Securities upgraded DLocal from Hold to Buy, pointing to new CEO Pedro Arnt’s turnaround efforts and recent third-quarter earnings that exceeded expectations. The upgrade highlights easing worries about pressure on DLocal’s take rates, with Truist’s net take rate outlook now closely matching broader market forecasts. Next, we’ll examine how Truist’s renewed confidence in CEO Pedro Arnt’s turnaround efforts could influence DLocal’s broader investment narrative. The...

Earlier this month, BioMarin Pharmaceutical’s CEO reported that the company’s US$500 million cost transformation program is about two-thirds complete and reiterated an ambition to reach a 40% non-GAAP operating margin next year, while also reshaping the portfolio through workforce reductions and discontinuation of the Roctavian program. At the same time, analysts have raised concerns about rising competition in achondroplasia and potential gaps in BioMarin’s pipeline, even as they...

Earlier this week, Goldman Sachs initiated coverage on Boot Barn Holdings with a positive rating and a US$225 price objective, highlighting the retailer’s expanded target for new store openings and its recent milestone of surpassing 500 locations across the United States. The firm’s view that Boot Barn could outperform sales expectations by accelerating store expansion underscores how brick‑and‑mortar growth remains central to the company’s trajectory despite broader retail shifts. We’ll now...